Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287

GlobeNewswireJan 8 21:00

Gain Therapeutics Appoints New CEO Amidst Clinical Progress

TipRanksJan 8 06:27

Gain Therapeutics Says Gianluca Fuggetta Appointed Principal Financial Officer >GANX

Dow JonesJan 7 20:01

Express News | Gain Therapeutics Appoints Gene Mack as Chief Executive Officer and Director

BreakingsJan 7 20:00

Gain Therapeutics' GT-02287 Study to Deliver Positive Findings, Says Roth MKM

Yahoo FinanceDec 25, 2024 20:40

Roth MKM Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $7

Futu NewsDec 24, 2024 21:32 · Ratings